| Guggulsterone ameliorates ethidium bromide-induced experimental model of multiple sclerosis via restoration of behavioral, molecular, neurochemical and morphological … N Kumar, N Sharma, R Khera, R Gupta, S Mehan Metabolic brain disease 36, 911-925, 2021 | 41 | 2021 |
| Dysregulation of sirt-1 signaling in multiple sclerosis and neuroimmune disorders: A systematic review of sirtuin activators as potential immunomodulators and their influences … N Sharma, A Shandilya, N Kumar, S Mehan Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2021 | 21 | 2021 |
| Connection between JAK/STAT and PPARγ signaling during the progression of multiple sclerosis: Insights into the modulation of T-cells and immune responses in the brain N Kumar, N Sharma, S Mehan Current molecular pharmacology 14 (5), 823-837, 2021 | 20 | 2021 |
| Metabolic syndromes responsible for cervical cancer and advancement of nanocarriers for efficient targeted drug delivery-A review S Ashique, A Upadhyay, N Kumar, S Chauhan, N Mishra Advances in Cancer Biology-Metastasis 4, 100041, 2022 | 16 | 2022 |
| The importance of gut-brain axis and use of probiotics as a treatment strategy for multiple sclerosis N Kumar, NK Sahoo, S Mehan Multiple sclerosis and related disorders 71, 104547, 2023 | 15 | 2023 |
| Effect of natural adenylcyclase/cAMP/CREB signalling activator forskolin against intra-striatal 6-OHDA-lesioned Parkinson’s rats: preventing mitochondrial, motor and … M Alharbi, A Alshammari, G Kaur, S Kalra, S Mehan, M Suri, S Chhabra, ... Molecules 27 (22), 7951, 2022 | 10 | 2022 |
| Forskolin, an Adenylcyclase/cAMP/CREB signaling activator restoring myelin-associated oligodendrocyte destruction in experimental ethidium bromide model of multiple sclerosis T Kapoor, S Mehan, M Suri, N Sharma, N Kumar, AS Narula, ... Cells 11 (18), 2771, 2022 | 7 | 2022 |
| Current landscape of therapeutics for the management of hypertension-a review N Fatima, S Ashique, A Upadhyay, S Kumar, H Kumar, N Kumar, P Kumar Current Drug Delivery 21 (5), 662-682, 2024 | 3 | 2024 |
| Ayurvedic Treatment of Bipolar Disorder R Kumar, C Singh, S Tyagi, N Kumar American Journal of Biomedical Research 9 (1), 5-9, 2021 | 1 | 2021 |
| Formulation of Solid Lipid Nanoparticles Loaded with Rosiglitazone and Probiotic: Optimization and In-vitro Characterization N Kumar, N Tyagi, S Mehan, AP Singh Recent Patents on Nanotechnology 18 (4), 527-542, 2024 | | 2024 |
| A Critical Review on the Role of Probiotics in Lung Cancer Biology and Prognosis S Ashique, N Mishra, A Garg, N Kumar, Z Khan, S Mohanto, ... Archivos de Bronconeumología, 2024 | | 2024 |
| Role of Synbiotics on Modulation of Inflammation B Verma, S Ashique, N Mishra, N Kumar, N Tyagi, S Kumar, D Ingawale, ... Synbiotics in Human Health: Biology to Drug Delivery, 25-54, 2024 | | 2024 |
| Unlocking the Secrets of Probiotics–A Therapeutic Breakthrough for Major Depressive Disorders S Ashique, M Faiyazuddin, M Bhowmick, S Ghazanfar, N Kumar, P Kumar, ... | | 2024 |
| ‘Convalescent Plasma’-An Effective Treatment Option to Prevent Emerging nCOVID-19-A Review S Ashique, T Khatun, G Sahu, A Upadhyay, A Adhana, S Kumar, ... Infectious Disorders-Drug Targets (Formerly Current Drug Targets-Infectious …, 2022 | | 2022 |
Sidharth MehanProfessor in Division of Neuroscience, Dept. of Pharmacology, ISF College of Pharmacy, Punjab, India在 isfcp.org 的电子邮件经过验证
Sidharth MehanProfessor in Division of Neuroscience, Dept. of Pharmacology, ISF College of Pharmacy, Punjab, India在 isfcp.org 的电子邮件经过验证
Mr. Sumel AshiqueBengal College of Pharmaceutical Sciences & Research, Durgapur, West Bengal, India